Patents by Inventor Angela J. Lumsden

Angela J. Lumsden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ocular tear growth factor-like protein
    Patent number: 7459440
    Abstract: The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: December 2, 2008
    Assignee: University of Virginia Patent Foundation
    Inventors: Gordon W. Laurie, Sandhya Sanghi, Kumar Rajesh, Angela J. Lumsden
  • Ocular tear growth factor-like protein
    Patent number: 7320870
    Abstract: The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: January 22, 2008
    Assignee: University of Virginia Patent Foundation
    Inventors: Gordon W. Laurie, Sandhya Sanghi, Kumar Rajesh, Angela J. Lumsden
  • Ocular tear growth factor-like protein
    Publication number: 20040081984
    Abstract: The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.
    Type: Application
    Filed: August 19, 2003
    Publication date: April 29, 2004
    Inventors: Gordon W. Laurie, Sandhya Sanghi, Kumar Rajesh, Angela J. Lumsden